Day: September 4, 2023

Global Neopentyl Glycol (NPG) Market Size to Reach USD 2.42 Billion in 2032 | Emergen Research

Rapid expansion in the construction and architectural sector is a major factor driving Neopentyl Glycol (NPG) market revenue growth Vancouver, Sept. 04, 2023 (GLOBE NEWSWIRE) — The global market for Neopentyl Glycol (NPG) attained a value of USD 1.47 Billion in the year 2022. As indicated by the latest analysis conducted by Emergen Research, this market is poised to achieve a consistent Compound Annual Growth Rate (CAGR) of 5.1% throughout the forecast period. This growth is substantially influenced by the rapid expansion within the automotive and construction sectors. The automotive and construction industries are experiencing robust expansion, serving as pivotal drivers for the augmentation of market revenue. The application of NPG-based coatings has gained prominence within the construction domain, finding extensive use in architectural...

Continue reading

Self-Defense Products Specialist Byrna Technologies Establishes Itself as an Innovator in the Less Lethal Weapons Space

Byrna Technologies has achieved significant and sustained revenue growth, demonstrating its appeal to consumers who are attracted to less lethal self-defense products. Andover, Massachusetts, Sept. 04, 2023 (GLOBE NEWSWIRE) — Andover, Massachusetts August 24, 2023, updated September 1, 2023 More than 300,000 Byrna SD Launchers Sold Since Shipping began in June 2019 Byrna Technologies Inc. (“Byrna” or the “Company”) (NASDAQ: BYRN) announced earlier this year that it had reached a revenue milestone, capping off four years of impressive growth. Revenues increased from $924 thousand in fiscal 2019, the year Byrna began to sell its launchers, to a record $48 million of net revenue for the fiscal year ended November 30, 2022. Byrna’s early focus has been providing American gun owners with a safe, effective, and reliable less-lethal...

Continue reading

No. 13/2023 – Managers’ transactions

Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen, 4 September 2023 ANNOUNCEMENT no. 13/2023 Managers’ transactions Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 4 September 2023. Details of the person discharging managerial responsibilities/person closely associated   Name: Jarosław Lipiński Reason for the notification:   Position/status: CEO in Cemat A/S Initial notification/Amendment: Initial Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor   Name: Cemat A/S LEI: 213800899MWAZT9KQZ78       Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each...

Continue reading

ICG Enterprise Trust Plc: Voting Rights and Capital

ICG Enterprise Trust plc (the “Company”) 4 September 2023 Voting Rights and Capital In accordance with the FCA’s Disclosure Guidance and Transparency Rule 5.6.1R the Company would like to notify the market of the following: At the close of business on the 31 August 2023, the Company had 72,913,000 Ordinary shares in issue, of which 5,279,107 were held in Treasury. Therefore, the total number of voting rights in the Company was 67,633,893. The above figure 67,633,893 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules. Analyst / Investor enquiries: Chris HuntShareholder Relations, ICG+44 (0) 20 3545 2020 Andrew LewisCompany Secretary,...

Continue reading

Information on share capital and voting rights – August 2023

Information on share capital and voting rights August 2023 Statement made in accordance with article L. 233-8 II of the French commercial Code and articles 221-1 2 ° f) and 223-16 of the AMF Regulations.                          September 4th, 2023 Statement made by:        Nexans S.A.Registered office : 4 Allée de l’Arche – 92400 CourbevoieRCS Nanterre 393 525 852Regulated market of Euronext Paris (Compartment A) Date   Total number of shares   Total number of voting rights Theorical (1) Exercisable (2) August 31st, 2023 43,753,380 43,753,380 43,706,473 (1)   Calculated based on all shares with voting rights, including treasury shares stripped of voting rights (Art. 223-11 of AMF General Regulations). (2)    For information, excluding treasury shares stripped of voting rights, excluding liquidity contract. Provision of...

Continue reading

Gulf Resources Announces it has updated the letter from Chief Executive Officer on its website

SHOUGUANG, China, Sept. 04, 2023 (GLOBE NEWSWIRE) — Gulf Resources, Inc. (Nasdaq:GURE) (“Gulf Resources” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that it has updated the letter from Chief Executive Officer on its website. The Company has recently updated the letter from its Chief Executive Officer , Mr Xiaobin liu on its website. Just simply click on the link below:http://www.gulfresourcesinc.com/about-7.html About Gulf Resources, Inc. Gulf Resources, Inc. operates through four wholly-owned subsidiaries, Shouguang City Haoyuan Chemical Company Limited (“SCHC”), Shouguang Yuxin Chemical Industry Co., Limited (“SYCI”), Daying County Haoyuan Chemical Company Limited (“DCHC”) and Shouguang Hengde Salt Industry...

Continue reading

Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at 35th International Epilepsy Congress

New interim data from ongoing Phase 2b X-TOLE open-label extension demonstrates improvement in overall quality-of-life (QoL) when compared to baseline Clinically important improvements seen for all patients across important subscales of Seizure Worry, Social Functioning and Medication Effects and for seizure free patients across all QoL subscales Oral presentations showcase Phase 3 clinical trials in focal onset seizures and primary generalized tonic-clonic seizures VANCOUVER, British Columbia, Sept. 04, 2023 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced a summary of its oral and poster presentations at the 35th International Epilepsy Congress (IEC) taking place in Dublin, Ireland from September 2-6, 2023. Mr. Ian Mortimer, Xenon’s President and Chief...

Continue reading

Form 8.3 – Octopus Investments – Ergomed plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1.        KEY INFORMATION   (a)        Full name of discloser: OCTOPUS INVESTMENTS LTD (b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Ergomed plc (d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:   (e)        Date position held/dealing...

Continue reading

Fang Holdings Announces Receipt of Non-Binding “Going Private” Proposal

BEIJING, Sept. 04, 2023 (GLOBE NEWSWIRE) — Fang Holdings Limited (OTC: SFUNY) (“Fang” or the “Company”), a leading real estate Internet portal in China, today announced that its board of directors (the “Board”) has received a preliminary non-binding proposal letter (the “Proposal Letter”), dated September 4, 2023, from Mr. Jiangong Dai (“Mr. Dai” or the “Proposing Buyer”), proposing to acquire all outstanding Class A ordinary shares (the “Class A Shares”) and Class B ordinary shares (the “Class B Shares”) (collectively, the “Shares”) of the Company, including Class A Shares represented by American depositary shares (the “ADSs”, each Class A ordinary share representing ten ADSs), that are not currently owned by the Proposing Buyer in a “going-private” transaction at a proposed purchase price of US$0.619 per Class A Share or US$6.19...

Continue reading

Cloud Dictation Solution Market to Surpass USD 2096.7 Million by 2030, exhibiting a CAGR of 11.9%

As per the report by Fortune Business Insights, the global cloud dictation solution market size is projected to reach USD 2096.7 million in 2030, at a CAGR of 11.9% during the forecast period, 2023-2030 Cloud Dictation Solution Market Forecast, 2023 – 2030 Pune, India, Sept. 04, 2023 (GLOBE NEWSWIRE) — Global cloud dictation solution market size was valued at USD 860.3 million in 2022 and is projected to reach USD 2096.7 million by 2030, exhibiting a CAGR of 11.9% during the forecast period. Fortune Business Insights has presented this information in their latest report titled “Global Cloud Dictation Solution Market Forecast, 2023-2030.” The cloud dictation solution tool used by users that allows them to change pronounced words into text using cloud-based servers and machine learning algorithms. The application...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.